Fri, Aug 29, 2014, 7:34 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

byotekprofessnl 1 post  |  Last Activity: Jun 17, 2014 4:03 PM Member since: Feb 29, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • byotekprofessnl by byotekprofessnl Jun 17, 2014 4:03 PM Flag

    I spoke to a friend of mine who is a doctor and has many drug reps visiting him each week. He is not into the market and was not familiar with CLVS, although he understood the field of study. What he said is Hyperglycemia is a very common side effect with many drugs that have FDA approval and are usually given with a complimentary drug to control this. He said he didn't see this as an issue for FDA approval and certainly was one of the least dangerous side effects of some of the other drugs that are currently on the market.

    I also believe that we have major drug companies looking at CLVS since it was $80 and it would make more sense to make a move on the company at $40 then wait for the FDA approval and the stock back up to $90.

SNTA
4.00-0.03(-0.74%)Aug 29 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.